TY - JOUR
T1 - Marek's disease virus
T2 - lytic replication, oncogenesis and control
AU - Jarosinski, Keith W
AU - Tischer, B Karsten
AU - Trapp, Sascha
AU - Osterrieder, Nikolaus
PY - 2006
Y1 - 2006
N2 - Marek's disease (MD) is caused by a ubiquitous, lymphotropic alphaherpesvirus, MD virus (MDV). MD has been a major concern in the poultry industry owing to the emergence of increasingly virulent strains over the last few decades that were isolated in the face of comprehensive vaccination. The disease is characterized by a variety of clinical signs; among them are neurological symptoms, chronic wasting and, most notably, the development of multiple lymphomas that manifest as solid tumors in the viscera and musculature. Much work has been devoted to study MD-induced oncogenesis and the genes involved in this process. Among the many genes encoded by MDV, a number have been shown recently to affect the development of tumors in chickens, one protein directly causing transformation of cells (Meq) and another being involved in maintaining transformed cells (vTR). Other MDV gene products modulate and are involved in early lytic in vivo replication, thereby increasing the chance of transformation occurring. In this review, we will summarize specific genes encoded by MDV that are involved in the initiation and/or maintenance of transformation and will focus mostly on current vaccination and control strategies against MD, particularly how modern molecular biological methods may be used to improve strategies to combat the disease in the future. © 2006 Future Drugs Ltd.
AB - Marek's disease (MD) is caused by a ubiquitous, lymphotropic alphaherpesvirus, MD virus (MDV). MD has been a major concern in the poultry industry owing to the emergence of increasingly virulent strains over the last few decades that were isolated in the face of comprehensive vaccination. The disease is characterized by a variety of clinical signs; among them are neurological symptoms, chronic wasting and, most notably, the development of multiple lymphomas that manifest as solid tumors in the viscera and musculature. Much work has been devoted to study MD-induced oncogenesis and the genes involved in this process. Among the many genes encoded by MDV, a number have been shown recently to affect the development of tumors in chickens, one protein directly causing transformation of cells (Meq) and another being involved in maintaining transformed cells (vTR). Other MDV gene products modulate and are involved in early lytic in vivo replication, thereby increasing the chance of transformation occurring. In this review, we will summarize specific genes encoded by MDV that are involved in the initiation and/or maintenance of transformation and will focus mostly on current vaccination and control strategies against MD, particularly how modern molecular biological methods may be used to improve strategies to combat the disease in the future. © 2006 Future Drugs Ltd.
KW - Herpesvirus
KW - Marek's disease virus
KW - Oncogenes
KW - Oncogenesis
KW - Vaccine
KW - Herpesvirus
KW - Marek's disease virus
KW - Oncogenes
KW - Oncogenesis
KW - Vaccine
KW - Herpesvirus
KW - Marek's disease virus
KW - Oncogenes
KW - Oncogenesis
KW - Vaccine
UR - http://www.scopus.com/inward/record.url?scp=33845864434&partnerID=8YFLogxK
UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-33845864434&origin=recordpage
U2 - 10.1586/14760584.5.6.761
DO - 10.1586/14760584.5.6.761
M3 - RGC 21 - Publication in refereed journal
C2 - 17184215
SN - 1476-0584
VL - 5
SP - 761
EP - 772
JO - Expert Review of Vaccines
JF - Expert Review of Vaccines
IS - 6
ER -